According to FutureWise analysis the market for chronic kidney disease diagnostics in 2023 was US$ 0.85 billion, and is expected to reach US$ 1.44 billion by 2031 at a CAGR of 6.7%.
Chronic kidney disease symptoms like blood in urine, swollen joints, foamy urine, etc are seldom noticed by patients resulting in progressive loss of kidney functions and ultimately renal failure. Delayed diagnosis, lack of sufficient epidemiological data, the significant cost involved in end-stage renal diseases as well as mild kidney diseases have resulted in a substantial need for chronic kidney disease diagnostics. Apart from physical examination by healthcare professionals, certain diagnostics like biopsy or procedures like blood and urine test provide vital stats and early signs about patients neurological, blood vessels and organ conditions. Based on such diagnostic results healthcare professionals can effectively control the kidney symptoms and avoid the progression of chronic kidney disease in their patients.
Factors boosting the chronic kidney disease diagnostics market:
Besides increased susceptibility of the ageing population due to degrading immune system, diabetics, cardiovascular issues are expected to fuel the growth of the global chronic kidney diseases diagnostics market during the forecast period.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Chronic-Kidney-Disease/137
Chronic Kidney Disease Diagnostics Market Segmentation:
By Product Type
By End-User
By Region
Competitive Landscape in the Chronic Kidney Disease Diagnostics Market:
Buy now the latest version of this report:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=137&license=single
**Objectives of this Study: **
Flexible Delivery Model:
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com